AzTrials
AzTrials

Research institution

Peking Union Medical College Hospital Clinical Trials

Studies where Peking Union Medical College Hospital is the lead sponsor: what is enrolling now, by phase, condition and country.

1,148 registered studies

In numbers

Open to volunteers
308
Active
337
With results posted
8
All registered
1,148

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 308
  • Gastrointestinal Neuroendocrine Carcinoma, Adjuvant Treatment

    Oxaliplatin-Based Adjuvant Therapy for Gastrointestinal Neuroendocrine Carcinoma**

    • Enrolling by invitation
    • Age: 18 to 75 years
    • Observational study

    Patients with pathologically-confirmed gastrointestinal neuroendocrine carcinoma will be enrolled, to explore the efficacy and safety of oxaliplatin-based doublet chemotherapy in the adjuvant treatment of gastrointestinal…

    Conditions
    Gastrointestinal Neuroendocrine Carcinoma, Adjuvant Treatment, Resection
    Trial name
    NCT07891572
    Where
    China
    Volunteers
    42 people
    Sponsor
    Peking Union Medical College Hospital
    Can I take part? NCT07891572
  • Hepatocellular Carcinoma (HCC)

    68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma

    • Recruiting
    • Age: 18 years and older
    • Phase 1/2
    • Injection or infusion

    This is a prospective, single-center, single-arm, phase I/II study designed to evaluate (1) the safety, tolerability, and imaging characteristics of 68Ga-NYM207 (Phase A), and (2) the diagnostic performance of 68Ga-NYM207 in…

    Trial name
    NYHCC (NCT07590336)
    Testing
    68Ga-NYM207 PET/CT
    Where
    China
    Volunteers
    100 people
    Sponsor
    Peking Union Medical College Hospital
    Can I take part? NYHCC
  • Sepsis

    Perfusion Efficiency-Guided MAP De-escalation in Elderly Septic Shock

    • Not yet recruiting
    • Age: 65 years and older

    This is a single-center, prospective, randomized crossover physiological trial conducted in elderly patients (≥65 years) with septic shock in the intensive care unit (ICU).

    Trial name
    NCT07887854
    Testing
    Ascending MAP titration sequence, Descending MAP titration sequence
    Volunteers
    24 people
    Sponsor
    Peking Union Medical College Hospital
    Can I take part? NCT07887854
  • Breast Cancer

    Hypofractionated Online Adaptive Radiotherapy of Breast Cancer

    • Recruiting
    • Age: 35 to 70 years
    • Phase 2
    • Surgery or procedure

    The goal of this clinical trial is to explore the application of online adaptive radiotherapy in patients who receive moderate hypofractionated or ultrafractionated radiotherapy after breast cancer surgery.

    Trial name
    NCT06568705
    Testing
    Moderate hypofractionated Radiation Treatment, Ultrafractionated Radiation Treatment
    Where
    China
    Volunteers
    40 people
    Sponsor
    Peking Union Medical College Hospital
    Can I take part? NCT06568705
  • Nonischemic Cardiomyopathy

    FAPI PET Imaging in Nonischemic Cardiomyopathy

    • Recruiting
    • Age: 18 to 90 years
    • Phase 2
    • Injection or infusion

    This study aims to evaluate the clinical value of [¹⁸F]AlF-NOTA-FAPI-04 PET/CT for the noninvasive assessment of myocardial fibroblast activation in patients with nonischemic cardiomyopathy.

    Trial name
    FAPI-NICM (NCT07878338)
    Testing
    [¹⁸F]AlF-NOTA-FAPI-04
    Where
    China
    Volunteers
    400 people
    Sponsor
    Peking Union Medical College Hospital
    Can I take part? FAPI-NICM
  • Inherited Retinal Diseases

    Extension Study of the PUMCH-E101 Clinical Trial:Safety and Efficacy Study of PUMCH-E101 Injection in the Contralateral Eye

    • Enrolling by invitation
    • Age: 8 to 45 years
    • Early Phase 1
    • Injection or infusion

    The goal of this clinical trial is to evaluate the safety and efficacy of PUMCH-E101 injection in the contralateral eye of subjects with RDH12 retinopathy.

    Trial name
    NCT07878572
    Testing
    PUMCH-E101 Injection(High dose)
    Where
    China
    Volunteers
    8 people
    Sponsor
    Peking Union Medical College Hospital
    Can I take part? NCT07878572
  • IgG4 Related Disease

    Tripterygium Wilfordii Plus Prednisone for Active IgG4-Related Disease

    • Not yet recruiting
    • Age: 45 to 79 years
    • Phase 2
    • Pill or oral medicine

    The goal of this clinical trial is to learn if tripterygium wilfordii added to prednisone can treat active IgG4-related disease (IgG4-RD) in adults 45 to 80 years of age. Women in the study must be postmenopausal.

    Trial name
    NCT07878585
    Testing
    Prednisone, tripterygium wilfordii
    Where
    China
    Volunteers
    74 people
    Sponsor
    Peking Union Medical College Hospital
    Can I take part? NCT07878585
  • Cervical Neuroendocrine Carcinoma

    Multi-omics Study of Cervical Neuroendocrine Carcinoma

    • Not yet recruiting
    • Age: 18 to 100 years
    • Observational study

    This is a retrospective study using archived tumor tissue and medical records from patients with cervical neuroendocrine carcinoma treated at Peking Union Medical College Hospital since January 1, 2015.

    Trial name
    NCT07879339
    Testing
    Multi-omics profiling of archived tumor tissue (observational)
    Where
    China
    Volunteers
    120 people
    Sponsor
    Peking Union Medical College Hospital
    Can I take part? NCT07879339
  • Thoracoabdominal Aortic Aneurysm, Endovascular Repair

    Clinical Trial of BAO-G Technique in Complex Aortic Aneurysm Endovascular Repair (BAO-G-02)

    • Recruiting
    • Age: 18 to 80 years
    • Surgery or procedure

    Multi-Branch AOrtic Reconstruction With G-iliac System (BAO-G) Technique is a novel technique of endovascular repair of complex aortic aneurysm, which using off-the-shelf iliac branched devices to reconstruct the visceral…

    Conditions
    Thoracoabdominal Aortic Aneurysm, Endovascular Repair, Complex Aortic Aneurysms
    Trial name
    BAO-G-02 (NCT07141251)
    Testing
    BAO-G
    Where
    11 sites in China
    Volunteers
    60 people
    Sponsor
    Peking Union Medical College Hospital
    Can I take part? BAO-G-02
  • Biliary Tract Cancer (BTC)

    Polymeric Micellar Paclitaxel-Based Combination Therapy for Advanced Biliary Tract Cancer

    • Recruiting
    • Age: 18 to 74 years
    • Phase 2

    After the standard first-line treatment, the treatment regimen was adjusted to a paclitaxel polymer micellar-based immunotherapy combination regimen

    Trial name
    PILOT-BTC (NCT07159204)
    Testing
    Paclitaxel polymer micelle immunocombination
    Where
    China
    Volunteers
    25 people
    Sponsor
    Peking Union Medical College Hospital
    Can I take part? PILOT-BTC

Completed, with results posted

All –

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in